Direct thrombin inhibitors, but not the direct factor Xa inhibitor rivaroxaban, increase tissue factor-induced hypercoagulability in vitro and in vivo

BACKGROUND: Increased hypercoagulability has been reported with low doses of direct thrombin inhibitors but not with direct factor Xa inhibitors. OBJECTIVES: To compare the effects of rivaroxaban with those of melagatran and dabigatran on thrombin generation (TG) and tissue factor-induced hypercoagu...

Descripción completa

Detalles Bibliográficos
Autores principales: Perzborn, E, Heitmeier, S, Buetehorn, U, Laux, V
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Clinical Haemostasis and Thrombosis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4285304/
https://www.ncbi.nlm.nih.gov/pubmed/24766850
http://dx.doi.org/10.1111/jth.12591

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4285304/
https://www.ncbi.nlm.nih.gov/pubmed/24766850
http://dx.doi.org/10.1111/jth.12591

Ejemplares similares